期刊文献+

头孢哌酮舒巴坦钠不同给药方案的疗效和经济学评价 被引量:15

Clinical Efficacy and Pharmaceutical Economics of Different Dosing Regimens of Cefoperazone Sodium and Sulbactam Sodium
原文传递
导出
摘要 目的探索头孢哌酮舒巴坦钠不同给药方案的临床疗效和药物经济学。方法根据说明书提供的药动学参数和美国临床实验室标准化协会药敏MIC解释标准计算不同方案%T〉MIC值,以%T〉MIC值≥50%为标准评估有效性和经济性。分析本院8年常用抗菌药物耐药资料。结果 %T〉MIC值≥50%方案:①1.5 g,q12h组对敏感级;②1.5 g,q8h和3.0 g,q12h组对敏感、中介级;③1.5 g,q6h、3.0 g,q8h和3.0 g,q6h组对敏感、中介、耐药级。3.0 g,q8h组和1.5 g,q6h组%T〉MIC值相似,但后者更低价、高效。头孢哌酮舒巴坦钠治疗病例59例,超说明书用药占89.83%,总有效率为79.24%。结论头孢哌酮舒巴坦钠说明书中q12h用药方案难以适应当前细菌严重耐药状况下临床治疗需求,中重度或多重耐药细菌感染治疗须用q6~8h方案。 OBJECTIVE To explore the clinical efficacy and pharmaceutical economics of different dosing regimens of cefoperazone sodium and sulbactam sodium. METHODS The values of %T〉MIC of different dosing regimens were calculated by referencing the pharmacokinetic parameters of drug introductions and drug sensitive MIC interpretation standard of Clinical and Laboratory Standards Institute. The clinical efficacy and pharmaceutical economics was evaluated by the standard of(%T〉MIC)≥50%. The drug resistance of commonly used antibiotics of our hospital in the 8 years was analysed. RUSULTS Scheme of(%T〉MIC)≥50%: ①1.5 g, q12 h group was sensitive grade; ②1.5 g, q8 h, 3.0 g, q12 h groups were sensitive, medium level; ③1.5 g, q6 h, 3.0 g, q8 h and 3.0 g, q6 h groups were sensitive, medium and drug resistance. The(%T〉MIC) values were basically similar between the 3.0 q8 h group and 1.5 q6 h group, but 1.5 q6 h group was more cheap and efficient. Cefoperazone sodium and sulbactam sodium was used to treat 59 cases. The over instruction rate was 89.83%. The total effective rate was 79.24%. CONCLUSION The drug regimen(q12h) of drug introduction of cefoperazone sodium and sulbactam sodium can not meet the needs of clinical treatment under the situation of serious bacteria resistance. Severe or multiple drug resistant bacterial infections must be administered by q6-8h. The research and legislation of off-label drug use are imperative.
出处 《中国现代应用药学》 CAS CSCD 2016年第1期110-114,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 头孢哌酮钠舒巴坦钠 药动学/药效学 %T〉MIC 临床药学 药品说明书 给药方案 cefoperazone sodium and sulbactam sodium pharmacokinetics and pharmacodynamics %T〉MIC clinical pharmacy drug instructions dosing regimens
  • 相关文献

参考文献17

二级参考文献44

  • 1邹多武,许国铭,苏暾,陆建萍.复方阿嗪米特治疗功能性消化不良、慢性胆囊炎、胆结石、肝硬化腹胀的疗效观察[J].中华消化杂志,2005,25(7):421-424. 被引量:97
  • 2张波,李大魁,杨晓.“药品说明书之外的用法”的若干问题及对策[J].继续医学教育,2006,20(28):86-88. 被引量:16
  • 3Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Dis-eases Society of America/American Thoracic Society consen-sus guidelines on the man agement of community-acquiredpneumonia in adults[J].Clin Infect Dis,2007,44(Suppl 2):S27-S72.
  • 4Tansarli GS, Rafailidis PI, Kapaskelis A, et al. Frequency of the off-label use of antibiotics in clinical practice: a systematic review [ J]. Expert Rev Anti Infect Ther, 2012,10:1383-1392.
  • 5CHEN B Y,HE L X,HU B J,et al.Expert consensus on diagnosis and prevention for Acinetobacter baumanniiinfection in China [J].中华医学杂志,2012,92(2):76-85.
  • 6SANFORD J P.The Sanford Guide To AntimicrobialTherapy(热病)[M].43rd Ed.Beijing:Peking Union MedicalCollege Press,2012:67.
  • 7WANG F,ZHANG Y Y.Anti-infective Therapy(实用抗感染治疗学)[M].2th Ed.Beijing:People's Health PublishingHouse,2012:303.
  • 8TUNKEL A R,HARMTMAN B J,KAPLAN S L,et al.Practice guideline for the management of bacterial meningitics[J].Clin Infect Dis,2004,39(9):1267-1284.
  • 9ZHANG Y Y.Study on early pathogenic diagnosis and meropenem treatment scheme optimization of central infection after operation [D].Shanghai:Fudan University,2011.
  • 10NAU R,LASSEK C,KINZIG-SCHIPPERS M,et al.Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy [J].Antimicrob Agents Chemother,1998,42(8):2012-2016.

共引文献401

同被引文献126

引证文献15

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部